Harvard Bioscience Inc

HBIO XNAS LABORATORY ANALYTICAL INSTRUMENTS

Market Cap

29M

Short interest (May 15)

2.7%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.47%

↓ 3.0%

Available Shares

200K

↓ 4.0%

Price Chart

Company Overview

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Company Info

Exchange: NASDAQ
Industry: LABORATORY ANALYTICAL INSTRUMENTS
CIK: 0001123494
Asset Type: CS

Market Data

Market Cap: $29,135,775
Employees: 339
Status: Active

Short Interest

Current Borrow Fee 0.47%
Range: 0.47% - 0.47%
Available Shares 200K
Range: 150K - 200K

Recent Changes

Fee Change: ↓ 6.1%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime